DK662487A - Medikamenter - Google Patents

Medikamenter

Info

Publication number
DK662487A
DK662487A DK662487A DK662487A DK662487A DK 662487 A DK662487 A DK 662487A DK 662487 A DK662487 A DK 662487A DK 662487 A DK662487 A DK 662487A DK 662487 A DK662487 A DK 662487A
Authority
DK
Denmark
Prior art keywords
medicaments
antagonist
receptors
compound
conjunction
Prior art date
Application number
DK662487A
Other languages
English (en)
Other versions
DK662487D0 (da
Inventor
Michael Brian Tyers
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DK662487D0 publication Critical patent/DK662487D0/da
Publication of DK662487A publication Critical patent/DK662487A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK662487A 1986-12-17 1987-12-16 Medikamenter DK662487A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868630080A GB8630080D0 (en) 1986-12-17 1986-12-17 Medicaments

Publications (2)

Publication Number Publication Date
DK662487D0 DK662487D0 (da) 1987-12-16
DK662487A true DK662487A (da) 1988-06-18

Family

ID=10609121

Family Applications (1)

Application Number Title Priority Date Filing Date
DK662487A DK662487A (da) 1986-12-17 1987-12-16 Medikamenter

Country Status (10)

Country Link
EP (1) EP0272876B1 (da)
JP (1) JPS63246337A (da)
AT (1) ATE95704T1 (da)
AU (1) AU618943B2 (da)
CA (1) CA1314223C (da)
DE (1) DE3787796T2 (da)
DK (1) DK662487A (da)
ES (1) ES2059399T3 (da)
GB (1) GB8630080D0 (da)
ZA (1) ZA879459B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3822792C2 (de) * 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten
GB8816187D0 (en) * 1988-07-07 1988-08-10 Glaxo Group Ltd Medicaments
WO1993012817A1 (en) * 1991-12-20 1993-07-08 Warner-Lambert Company Therapeutic combinations useful in the treatment of gastroesophageal reflux disease
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
GB9312315D0 (en) * 1993-06-15 1993-07-28 Poston Robin Leukocyte adhesion assay
DK0723436T3 (da) * 1994-07-08 2001-11-26 Astrazeneca Ab Tabletteret flerenhedsdoseringsform
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
AU3290397A (en) * 1996-06-10 1998-01-07 Depomed, Inc. Gastric-retentive oral controlled drug delivery system with enhanced retention properties
SE0203410D0 (sv) * 2002-11-18 2002-11-18 Astrazeneca Ab New use
US20060235053A1 (en) * 2003-05-06 2006-10-19 Atlanta Pharma Ag Agents for the treatment of lower abdominal disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
GB2161160B (en) * 1984-07-06 1989-05-24 Fisons Plc Heterocyclic sulphinyl compounds
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
DE3771376D1 (de) * 1986-03-17 1991-08-22 Glaxo Group Ltd Indol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Also Published As

Publication number Publication date
DE3787796D1 (de) 1993-11-18
CA1314223C (en) 1993-03-09
ZA879459B (en) 1988-11-30
EP0272876A3 (en) 1988-07-27
DE3787796T2 (de) 1994-03-03
EP0272876B1 (en) 1993-10-13
GB8630080D0 (en) 1987-01-28
AU618943B2 (en) 1992-01-16
DK662487D0 (da) 1987-12-16
ATE95704T1 (de) 1993-10-15
AU8261587A (en) 1988-06-23
EP0272876A2 (en) 1988-06-29
ES2059399T3 (es) 1994-11-16
JPS63246337A (ja) 1988-10-13

Similar Documents

Publication Publication Date Title
BG60249B2 (en) Thiazole compound for treatment of ulcers
FR2617041B1 (fr) Orthese ou prothese pour la coordination des mouvements
DK0601386T3 (da) Sulfonamider
DE3650647D1 (de) Arzneimittel zur Behandlung von Anxietas
DK662487D0 (da) Medikamenter
SE8503207D0 (sv) Pharmacologically active substituted benzamides
IT8349596A0 (it) Preparato medicinale per la cura dell'ulcera gastroduodenale
IT9041529A0 (it) Dispositivo per la correzione chirurgica dell'ametropia
FR2556956B3 (fr) Prothese penienne semi-rigide pour le traitement des impuissances d'erection
SE8801845D0 (sv) Pharmacologically active substituted benzamides
FR2584073B1 (fr) Analogues d'amino-prostaglandines a substituant 5,6-epoxy-7-oxabicycloheptane, utilisables pour le traitement des thromboses
GB8630079D0 (en) Medicaments
FR2544614B1 (fr) Nouvelle association medicamenteuse pour le traitement de l'hypertension
BE877249A (fr) Dispositif pour l'epuration biologique d'eaux residuaires.
GB2135997B (en) N-(m-trifluoromethylphenyl)-n'-propargylpiperazine
IT1145433B (it) Composizione farmaceutiche impiegabili per il trattamento dell'ipertensione
FR2590245B1 (fr) Appareil pour le traitement anaerobie d'eaux usees
ATE31925T1 (de) 2-(formylamino)-n-(1h-tetrazol-5-yl)benzamide.
SE8801907D0 (sv) Novel pharmacological compounds
IT1181443B (it) Erettore pneumatico del pene dell'uomo
ITFI910146V0 (it) Plantare correttore alluce valgo - motodo sara - per la correzione completa dell' alluce valgo
IT7922956V0 (it) Coordinato portatile per l'igiene del cavo orale.
IT9067177A0 (it) Mezzi per il trattamento terapeutico dell'apnea durante il sonno
ITMI911450A0 (it) Endoapparecchio per il ripristino dell'articolazione coxofemorale
IT8919216A0 (it) Dispositivo per la cura chirurgica dell'astigmatismo.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment